659 related articles for article (PubMed ID: 27622765)
1. Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades in Microglia: Stronger Effects of the A53T Mutant.
Hoenen C; Gustin A; Birck C; Kirchmeyer M; Beaume N; Felten P; Grandbarbe L; Heuschling P; Heurtaux T
PLoS One; 2016; 11(9):e0162717. PubMed ID: 27622765
[TBL] [Abstract][Full Text] [Related]
2. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.
Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I
Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735
[TBL] [Abstract][Full Text] [Related]
3. Expression of mutant alpha-synuclein modulates microglial phenotype in vitro.
Rojanathammanee L; Murphy EJ; Combs CK
J Neuroinflammation; 2011 May; 8():44. PubMed ID: 21554732
[TBL] [Abstract][Full Text] [Related]
4. Apomorphine Reduces A53T α-Synuclein-Induced Microglial Reactivity Through Activation of NRF2 Signalling Pathway.
Heurtaux T; Kirchmeyer M; Koncina E; Felten P; Richart L; Uriarte Huarte O; Schohn H; Mittelbronn M
Cell Mol Neurobiol; 2022 Nov; 42(8):2673-2695. PubMed ID: 34415465
[TBL] [Abstract][Full Text] [Related]
5. Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism.
Liu Z; Yu Y; Li X; Ross CA; Smith WW
Pharmacol Res; 2011 May; 63(5):439-44. PubMed ID: 21237271
[TBL] [Abstract][Full Text] [Related]
6. alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice.
Shirakashi Y; Kawamoto Y; Tomimoto H; Takahashi R; Ihara M
Acta Neuropathol; 2006 Dec; 112(6):681-9. PubMed ID: 16957925
[TBL] [Abstract][Full Text] [Related]
7. Pathological α-synuclein exacerbates the progression of Parkinson's disease through microglial activation.
Zhang QS; Heng Y; Yuan YH; Chen NH
Toxicol Lett; 2017 Jan; 265():30-37. PubMed ID: 27865851
[TBL] [Abstract][Full Text] [Related]
8. Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein.
Zhang W; Dallas S; Zhang D; Guo JP; Pang H; Wilson B; Miller DS; Chen B; Zhang W; McGeer PL; Hong JS; Zhang J
Glia; 2007 Aug; 55(11):1178-88. PubMed ID: 17600340
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
10. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity.
Smith WW; Jiang H; Pei Z; Tanaka Y; Morita H; Sawa A; Dawson VL; Dawson TM; Ross CA
Hum Mol Genet; 2005 Dec; 14(24):3801-11. PubMed ID: 16239241
[TBL] [Abstract][Full Text] [Related]
11. Extracellular α-synuclein--a possible initiator of inflammation in Parkinson's disease.
Ren WQ; Tian ZM; Yin F; Sun JZ; Zhang JN
Pharmazie; 2016 Feb; 71(2):51-5. PubMed ID: 27004367
[TBL] [Abstract][Full Text] [Related]
12. GM1 ganglioside modifies microglial and neuroinflammatory responses to α-synuclein in the rat AAV-A53T α-synuclein model of Parkinson's disease.
Schneider JS; Singh G; Williams CK; Singh V
Mol Cell Neurosci; 2022 May; 120():103729. PubMed ID: 35447351
[TBL] [Abstract][Full Text] [Related]
13. Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice.
Gu XL; Long CX; Sun L; Xie C; Lin X; Cai H
Mol Brain; 2010 Apr; 3():12. PubMed ID: 20409326
[TBL] [Abstract][Full Text] [Related]
14. CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson's disease.
Li Y; Niu M; Zhao A; Kang W; Chen Z; Luo N; Zhou L; Zhu X; Lu L; Liu J
J Neuroinflammation; 2019 Dec; 16(1):263. PubMed ID: 31831012
[TBL] [Abstract][Full Text] [Related]
15. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.
Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F
J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303
[TBL] [Abstract][Full Text] [Related]
16. Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration.
Soria FN; Engeln M; Martinez-Vicente M; Glangetas C; López-González MJ; Dovero S; Dehay B; Normand E; Vila M; Favereaux A; Georges F; Lo Bianco C; Bezard E; Fernagut PO
Hum Mol Genet; 2017 Jul; 26(14):2603-2615. PubMed ID: 28520872
[TBL] [Abstract][Full Text] [Related]
17. Reactive macrophages increase oxidative stress and alpha-synuclein nitration during death of dopaminergic neuronal cells in co-culture: relevance to Parkinson's disease.
Shavali S; Combs CK; Ebadi M
Neurochem Res; 2006 Jan; 31(1):85-94. PubMed ID: 16475001
[TBL] [Abstract][Full Text] [Related]
18. A53T Mutant Alpha-Synuclein Induces Tau-Dependent Postsynaptic Impairment Independently of Neurodegenerative Changes.
Teravskis PJ; Covelo A; Miller EC; Singh B; Martell-Martínez HA; Benneyworth MA; Gallardo C; Oxnard BR; Araque A; Lee MK; Liao D
J Neurosci; 2018 Nov; 38(45):9754-9767. PubMed ID: 30249789
[TBL] [Abstract][Full Text] [Related]
19. Controlling aggregation propensity in A53T mutant of alpha-synuclein causing Parkinson's disease.
Kumar S; Sarkar A; Sundar D
Biochem Biophys Res Commun; 2009 Sep; 387(2):305-9. PubMed ID: 19580781
[TBL] [Abstract][Full Text] [Related]
20. P2X7 receptor is critical in α-synuclein--mediated microglial NADPH oxidase activation.
Jiang T; Hoekstra J; Heng X; Kang W; Ding J; Liu J; Chen S; Zhang J
Neurobiol Aging; 2015 Jul; 36(7):2304-2318. PubMed ID: 25983062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
